MAX-40279 hemiadipate 是 FLT3 激酶和 FGFR 激酶的双重有效抑制剂。MAX-40279 hemiadipate 具有研究急性髓性白血病 (AML) 的潜力 (信息提取自专利 WO2021180032A1)。
| Cas No. | 2388506-44-1 |
| 分子式 | C22H23FN6OS.1/2C6H10O4 |
| 分子量 | 584.66 |
| 溶解度 | DMSO : 25 mg/mL (42.76 mM; ultrasonic and warming and heat to 60℃)|DMF : 10 mg/mL (17.10 mM; ultrasonic and warming and heat to 60℃) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | MAX-40279 hemiadipate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemiadipate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. [1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
